These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7804514

  • 1. Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
    De Lima MD, Kohlmann NE, Neves FA, Zanella MT, Ribeiro AB, Kohlmann O.
    Blood Press Suppl; 1994; 4():53-6. PubMed ID: 7804514
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 4. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 5. Metabolic effects of enalapril in the treatment of essential hypertension.
    Oksa A, Stefíková K, Fedelesová V, Baculáková V, Spustová V, Dzúrik R.
    Cor Vasa; 1992 Jun; 34(4):329-41. PubMed ID: 1308725
    [Abstract] [Full Text] [Related]

  • 6. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
    Amodeo C, Barros LM, Batlouni M, Sousa JE.
    Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
    Oren S, Turkot S, Paran E, Flandra O, Slezak L, Hof B.
    J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
    [Abstract] [Full Text] [Related]

  • 11. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 12. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A, Basavanagowdappa H, Zawar S, Kumar A, Chandurkar N.
    Expert Opin Pharmacother; 2009 Jul 25; 10(10):1529-36. PubMed ID: 19514864
    [Abstract] [Full Text] [Related]

  • 13. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
    Uchida K, Azukizawa S, Kigoshi T, Nakano S, Kaneko M, Morimoto S, Matsui A.
    Clin Ther; 1994 Jul 25; 16(3):466-70. PubMed ID: 7923313
    [Abstract] [Full Text] [Related]

  • 14. Moderate sodium restriction and various diuretics in the treatment of hypertension.
    Ram CV, Garrett BN, Kaplan NM.
    Arch Intern Med; 1981 Jul 25; 141(8):1015-9. PubMed ID: 7247587
    [Abstract] [Full Text] [Related]

  • 15. [Captopril and hydrochlorothiazide combined in the treatment of mild-to-moderate hypertension. Evaluation of sugar and lipid metabolism in a long-term study].
    Malacco E, Magenta M, Noia E, Renesto E, Sartini C, Botta GF.
    Minerva Med; 1989 Oct 25; 80(10):1115-8. PubMed ID: 2682377
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urapidil in hypercholesterolemic hypertensive patients.
    Ferrara LA, Leonetti G, Fogari R, Mazzola C, Mancini M, Zanchetti A.
    Blood Press Suppl; 1994 Oct 25; 4():39-44. PubMed ID: 7804511
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Celiprolol improves glucose metabolism in essential hypertension].
    Oksa A, Fedelesová V, Spustová V, Dzúrik R.
    Vnitr Lek; 1998 Feb 25; 44(2):63-7. PubMed ID: 9820078
    [Abstract] [Full Text] [Related]

  • 20. [Fosinorm in the treatment of essential hypertension with a metabolic syndrome].
    Kobalava ZhD, Kotovskaia IuV, Moryleva ON, Drozdov VN, Ivleva AIa, Moiseev VS.
    Ter Arkh; 1997 Feb 25; 69(8):10-3. PubMed ID: 9381382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.